Brought to you by 
Cephalon licenses modafinil from Laboratoire L. Lafon
14 Dec 2001
Executive Summary
Cephalon will get immediate marketing experience and a product to make investors happy while it continues to research its in-house projects: it licensed narcolepsy drug modafinil from Laboratoire L. Lafon exclusively for the US and Mexico.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cephalon licenses modafinil from Laboratoire L. Lafon
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice